| Ident. | Authors (with country if any) | Title |
|---|
| 000265 |
James A. Miller [États-Unis] ; Briana R. Trout [États-Unis] ; Kelly A. Sullivan [États-Unis] ; Russell A. Bialecki [États-Unis] ; Ruth A. Roberts [Royaume-Uni] ; Ronald B. Tjalkens [États-Unis] | Low‐dose 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine causes inflammatory activation of astrocytes in nuclear factor‐κB reporter mice prior to loss of dopaminergic neurons |
| 000582 |
Kayhan A. Tayarani-Binazir [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Sarah Rose [Royaume-Uni] ; C. Warren Olanow [États-Unis] ; Peter Jenner [Royaume-Uni] | Pramipexole combined with levodopa improves motor function but reduces dyskinesia in MPTP‐treated common marmosets |
| 000603 |
Louisa Clare Johnston [Royaume-Uni] ; Michael John Jackson [Royaume-Uni] ; Sarah Rose [Royaume-Uni] ; Andrew Christopher Mccreary [Pays-Bas] ; Peter Jenner [Royaume-Uni] | Pardoprunox reverses motor deficits but induces only mild dyskinesia in MPTP‐treated common marmosets |
| 000C93 |
Madeleine Diedrich [Allemagne] ; Lei Mao [Allemagne] ; Christian Bernreuther [Allemagne] ; Claus Zabel [Allemagne] ; Grit Nebrich [Allemagne] ; Ralf Kleene [Allemagne] ; Joachim Klose [Allemagne] | Proteome analysis of ventral midbrain in MPTP‐treated normal and L1cam transgenic mice |
| 000C98 |
Peter Jenner [Royaume-Uni] | Preventing and controlling dyskinesia in Parkinson's disease—A view of current knowledge and future opportunities |
| 000D51 |
Riccardo Ruffoli [Italie] ; Paola Soldani [Italie] ; Livia Pasquali [Italie] ; Stefano Ruggieri [Italie] ; Antonio Paparelli [Italie] ; Francesco Fornai [Italie] | Methamphetamine Fails to Alter the Noradrenergic Integrity of the Heart |
| 000D87 |
Patrick L. Mcgeer [Canada] ; Edith G. Mcgeer [Canada] | Glial reactions in Parkinson's disease |
| 000F26 |
Risa Sakai [Japon] ; Yoshifumi Irie [Japon] ; Takeshi Murata [Japon] ; Atsushi Ishige [Japon] ; Naoko Anjiki [Japon] ; Kenji Watanabe [Japon] | Toki‐to protects dopaminergic neurons in the substantia nigra from neurotoxicity of MPTP in mice |
| 000F72 |
Timothy M. Fountaine [Royaume-Uni] ; Richard Wade-Martins [Royaume-Uni] | RNA interference‐mediated knockdown of α‐synuclein protects human dopaminergic neuroblastoma cells from MPP+ toxicity and reduces dopamine transport |
| 001219 |
Patrick Mclaughlin [États-Unis] ; Yong Zhou [États-Unis] ; Tracy Ma [États-Unis] ; Jun Liu [États-Unis] ; Wei Zhang [États-Unis] ; Jau-Shyong Hong [États-Unis] ; Monika Kovacs [États-Unis] ; Jing Zhang [États-Unis] | Proteomic analysis of microglial contribution to mouse strain–dependent dopaminergic neurotoxicity |
| 001223 |
Marc Morissette [Canada] ; Mehdi Dridi [Canada] ; Frédéric Calon [Canada] ; Abdallah Hadj Tahar [Canada] ; Leonard T. Meltzer [États-Unis] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada] | Prevention of levodopa‐induced dyskinesias by a selective NR1A/2B N‐methyl‐D‐aspartate receptor antagonist in parkinsonian monkeys: Implication of preproenkephalin |
| 001254 |
David W. Anderson [États-Unis] ; Kristin A. Bradbury [États-Unis] ; Jay S. Schneider [États-Unis] | Neuroprotection in Parkinson models varies with toxin administration protocol |
| 001350 |
Gloria E. Meredith [États-Unis] ; Un Jung Kang [États-Unis] | Behavioral models of Parkinson's disease in rodents: A new look at an old problem |
| 001462 |
Lance A. Smith [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Ghassan Al-Barghouthy [Royaume-Uni] ; Sarah Rose [Royaume-Uni] ; Mikko Kuoppamaki [Royaume-Uni, États-Unis] ; Warren Olanow [Finlande] ; Peter Jenner [Royaume-Uni] | Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP‐treated drug‐naïve primates |
| 001490 |
Silvia Mandel [Israël] ; Edna Grunblatt [Allemagne] ; Peter Riederer [Allemagne] ; Ninette Amariglio [Israël] ; Jasmine Jacob Hirsch [Israël] ; Gideon Rechavi [Israël] ; Moussa B. H. Youdim [Israël] | Gene Expression Profiling of Sporadic Parkinson's Disease Substantia Nigra Pars Compacta Reveals Impairment of Ubiquitin‐Proteasome Subunits, SKP1A, Aldehyde Dehydrogenase, and Chaperone HSC‐70 |
| 001545 |
Mahmoud M. Iravani [Royaume-Uni] ; Emilie Syed [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Louisa C. Johnston [Royaume-Uni] ; Lance A. Smith [Royaume-Uni] ; Peter Jenner [Royaume-Uni] | A modified MPTP treatment regime produces reproducible partial nigrostriatal lesions in common marmosets |
| 001726 |
Peter Teismann [États-Unis] ; Kim Tieu [États-Unis] ; Oren Cohen [États-Unis] ; Dong-Kug Choi [États-Unis] ; Du Chu Wu [États-Unis] ; Daniel Marks [États-Unis] ; Miquel Vila [États-Unis] ; Vernice Jackson-Lewis [États-Unis] ; Serge Przedborski [États-Unis] | Pathogenic role of glial cells in Parkinson's disease |
| 001778 |
Lance A. Smith [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Matthew J. Hansard [Royaume-Uni] ; Eleni Maratos [Royaume-Uni] ; Peter Jenner [Royaume-Uni] | Effect of pulsatile administration of levodopa on dyskinesia induction in drug‐naïve MPTP‐treated common marmosets: Effect of dose, frequency of administration, and brain exposure |
| 001857 |
Hagai Bergman [Israël] ; Günther Deuschl [Allemagne] | Pathophysiology of Parkinson's disease: From clinical neurology to basic neuroscience and back |
| 001A17 |
Diana Frechilla [Espagne] ; Almudena Cobreros [Espagne] ; Laura Saldise [Espagne] ; Rosario Moratalla [Espagne] ; Ricardo Insausti [Espagne] ; M-Rosario Luquin [Espagne] ; Joaquín Del Río [Espagne] | Serotonin 5‐HT1A receptor expression is selectively enhanced in the striosomal compartment of chronic parkinsonian monkeys |
| 001A46 |
Claudio Da Cunha [Brésil] ; Monique S. Gevaerd [Brésil] ; Maria Aparecida B. F Vital [Brésil] ; Edmar Miyoshi [Brésil] ; Roberto Andreatini [Brésil] ; Rodolfo Silveira [Brésil] ; Reinaldo N. Takahashi [Brésil] ; Newton S. Canteras [Brésil] | Memory disruption in rats with nigral lesions induced by MPTP: a model for early Parkinson's disease amnesia |
| 001A84 |
Masashi Kitazawa [États-Unis] ; Vellareddy Anantharam [États-Unis] ; Anumantha G. Kanthasamy [États-Unis] | Dieldrin-induced oxidative stress and neurochemical changes contribute to apoptopic cell death in dopaminergic cells |
| 001B69 |
Sophie Callier [Canada, France] ; Marc Morissette [Canada] ; Michelle Grbois [Canada] ; Thérèse Di Paolo [Canada] | Stereospecific prevention by 17β‐estradiol of MPTP‐induced dopamine depletion in mice |
| 001D37 |
H. Boecker ; A. Ceballos-Baumann ; P. Bartenstein ; A. Weindl ; H. R. Siebner ; T. Fassbender ; F. Munz ; M. Schwaiger ; B. Conrad | Sensory processing in Parkinson's and Huntington's disease |
| 001D61 |
Martin Goulet ; Marc Morissette ; Richard Grondin ; Pierre Falardeau ; Paul J. Bédard ; William Rostène [France] ; Thérèse Di Paolo | Neurotensin receptors and dopamine transporters: Effects of MPTP lesioning and chronic dopaminergic treatments in monkeys |
| 001D96 |
A. L. Brownell [États-Unis] ; B. G. Jenkins [États-Unis] ; O. Isacson [États-Unis] | Dopamine imaging markers and predictive mathematical models for progressive degeneration in Parkinson's disease |
| 001F19 |
P. J. Blanchet [États-Unis] ; S. Konitsiotis [États-Unis] ; K. Hyland [États-Unis] ; L. A. Arnold [États-Unis] ; K. D. Pettigrew [États-Unis] ; T. N. Chase [États-Unis] | Chronic Exposure to MPTP as a Primate Model of Progressive Parkinsonism: A Pilot Study with a Free Radical Scavenger |
| 002009 |
Anumantha G. Kanthasamy [États-Unis] ; Arthi Kanthasamy [États-Unis] ; Rae R. Matsumoto [États-Unis] ; Toan Q. Vu [États-Unis] ; Daniel D. Truong [États-Unis] | Neuroprotective effects of the strychnine-insensitive glycine site NMDA antagonist ( R )-HA-966 in an experimental model of Parkinson's disease |
| 002318 |
Pj Blanchet [Canada] ; B. Gomez-Mancilla [Canada] ; T. Di Paolo [Canada] ; Pj Bédard [Canada] | Is striatal dopaminergic receptor imbalance responsible for levodopa‐induced dyskinesia? |
| 002554 |
M. T. Herrero [France] ; E. C. Hirsch [France] ; A. Kastner [France] ; M. Ruberg [France] ; M. R. Luquin [Espagne] ; J. Laguna [Espagne] ; F. Javoy-Agid [France] ; J. A. Obeso [Espagne] ; Yves Agid [Espagne] | Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP? |
| 002694 |
J. S. Schneider [États-Unis] ; D. S. Rothblat [États-Unis] | Neurochemical evaluation of the striatum in symptomatic and recovered mptp-treated cats |
| 002725 |
E. H. Heinonen [Finlande] ; R. Lammintausta [Finlande] | A review of the pharmacology of selegiline |
